Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users

Drug and Alcohol Dependence

Volumn 87, Issue 1, 2007, Pages 98-102

  Havens, Jennifer R ^a   Walker, Robert ^a   Leukefeld, Carl G ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Benzodiazepines; Injection drug use; Opioid analgesic; OxyContin ; Prescription drug

Indexed keywords

OPIATE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; HEPATITIS C; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SELF REPORT; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OXYCODONE; PREVALENCE; QUESTIONNAIRES; RURAL POPULATION; SUBSTANCE ABUSE, INTRAVENOUS;

HEPATITIS C VIRUS;

EID: 33846084982     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.07.008     Document Type: Article

References (35)

1. Abdala A., Crowe M., Tolstov Y., and Heimer R. Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions. Subst. Use Misuse 39 (2004) 591-600
2. Appalachian Regional Commission. County economic status, fiscal year 2004. Appalachian Regional Commission. Available at: http://www.arc.gov/index.do?nodeId=56 (accessed September 24, 2005).
3. Barendregt C., van der Poel A., and van de Mheen D. Tracing selection effects in three non-probability samples. Eur. Addict. Res. 11 3 (2005) 124-131
4. Bell J., Batey R.G., Farrell G.C., Crewe E.B., Cunningham A.L., and Byth K. Hepatitis C virus in intravenous drug users. Med. J. Aust. 153 (1990) 274-276
5. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, vol. 15, 2003. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta 2004, pp. 1-46. http://www.cdc.gov/hiv/stats/hasrlink.htm.
6. Chaisson R.E., Moss A.R., Onishi R., Osmond D., and Carlson J.R. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am. J. Public Health 77 (1987) 169-172
7. ® and other opioid analgesics in the United States: 2002-2004. J. Pain 6 (2005) 662-672
8. Darke S. Self-report among injection drug users: a review. Drug Alcohol Depend. 51 (1998) 523-563
9. Del Boca F.K., and Noll J.A. Truth or consequences: the validity of self-report data in health services research on addictions. Addiction 95 (2000) 347-360
10. Drummer O.H. Recent trends in narcotic deaths. Ther. Drug Monit. 27 (2005) 738-740
11. Earle C.W. The opium habit; a statistical and clinical lecture. Chicago Med. Rev. 2 (1880) 442-498
12. Falck R.S., Seigal H.A., Wang J., Carlson R.G., and Draus P.J. Nonmedical drug use among stimulant-using adults in small towns in rural Ohio. J. Subst. Abuse Treat. 28 (2005) 341-349
13. Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., and Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 91 (2001) 42-46
14. Hughes R.A. Drug injectors and the cleaning of needles and syringes. Eur. Addict. Res. 6 (2000) 20-30
15. Inciardi J., and Goode J.L. OxyContin and prescription drug diversion. Consumers' Res. Magaz. 86 (2003) 22-25
16. Jenkinson, R.A., Clark, N.C., Fry, C.L., Dobbin, M., 2005. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction 100, 197-205.
17. Kronstrand R., Druid H., Holmgren P., and Rajs J. A cluster of fentanyl-related deaths among drug addicts in Sweden. Forensic Sci. Int. 88 (1997) 185-193
18. Leukefeld C.G., Logan T.K., Farabee D., and Clayton R. Drug use and AIDS: estimating injection prevalence in a rural state. Subst. Use Misuse 37 (2002) 767-782
19. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 9 (1992) 199-213
20. Miller C.L., Strathdee S.A., Kerr T., Li K., and Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J. Adolesc. Health 38 4 (2006) 462-464
21. National Drug Intelligence Center, 2002. Kentucky drug threat assessment. U.S. Department of Justice. http://www.usdoj.gov/ndic/pubs1/1540/heroin.htm#Top (accessed 4/1/2005).
22. O'Donnell J.A., and Jones J.P. Diffusion of the intravenous technique among narcotic addicts. In: Ball J.C., and Chambers C.D. (Eds). The Epidemiology of Opiate Addiction in the United States (1970), Charles C. Thomas, Springfield, IL 147-164
23. Rutherford M.J., Cacciola J.S., Alterman A.I., McKay J.R., and Cook T.G. Contrasts between admitters and deniers of drug use. J. Subst. Abuse Treat. 18 (2000) 343-348
24. Schoenbaum E.E., Hartel D., Selwyn P.A., Klein R.S., Davenny K., Rogers M., Feiner C., and Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. N. Engl. J. Med. 321 (1989) 874-879
25. Substance Abuse and Mental Health Services Administration, 2004. Treatment admissions in urban and rural areas involving abuse of narcotic painkillers: 2002 update. The DASIS Report. U.S. Department of Health and Human Services, Rockville, MD, 2004.
26. Substance Abuse and Mental Health Services Administration, 2005. 2004 National Survey on Drug Use & Health. Downloaded on September 28, 2005 from http://www.drugabusestatistics.samhsa.gov/nsduh/2k4nsduh/2k4Results/2k4Results.htm#5.1.
27. Sherman S.G., Fuller C.M., Shah N., Ompad D.V., Vlahov D., and Strathdee S.A. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J. Psychoactive Drugs 37 4 (2005) 437-443
28. Stimson, C.V., 1993. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. United Nations Office on Drugs and Crime. Downloaded July 19, 2006 from http://www.unodc.org/unodc/bulletin/bulletin_1993-01-01_1_page002.html.
29. Terry C.E., and Pellens M. The Opium Problem (1928), Bureau of Social Hygiene, New York
30. Thomas D.L., Vlahov D., Solomon L., Cohn S., Taylor E., Garfein R., and Nelson K.E. Correlates of hepatitis C infections among injection drug users. Medicine (Baltimore) 74 (1995) 212-220
31. U.S.Census Bureau, 2000. United States Census 2000.
32. U.S. Department of Health and Human Services. National Institutes of Health. Community Epidemiology Work Group, 2004. Epidemiologic Trends in Drug Abuse. Advance Report: Prescription Drug Abuse. http://www.drugabuse.gov/PDF/CEWG/AdvReport604.pdf (accessed October 7, 2005).
33. Waldvogel D., Figner B., and Eich D. Illicit methadone injecting during methadone maintenance treatment in a specialised out-patient clinic. Swiss Med. Wkly. 135 (2005) 644-646
34. Walker, R., Logan, T.K., Bradshaw, G., Leukefeld, C., Goltz, M., Stevenson, E., 2004. Kentucky Substance Abuse Treatment Outcome Study: FY 2002 Follow-up Findings. University of Kentucky Center on Drug and Alcohol Research, Lexington, KY. http://cdar.uky.edu/ktos/ (accessed November 3, 2005).
35. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on the problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 69 (2003) 215-232